Trial Profile
IGF-1 and Bone Loss in Women With Anorexia Nervosa.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Mecasermin (Primary) ; Risedronic acid (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 13 Jul 2019 Status changed from active, no longer recruiting to completed.
- 09 Jan 2019 Planned End Date changed from 1 Mar 2019 to 1 Apr 2019.
- 09 Jan 2019 Planned primary completion date changed from 1 Mar 2019 to 1 Apr 2019.